Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming breast cancer treatment and prevention, announced the completion of a Type C ...
2d
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
IDEAYA Biosciences, Inc. ( IDYA) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:00 AM EST ...
She said there are struggles along the way for the Bills to meet targets of the CBA from investing in youth administrative ...
Welltica+ on MSN
Scientists uncover the cell’s secret weapon against aging
A new study reveals that reactivating the body’s natural cellular cleanup system could help slow or even reverse key processes of aging.
Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient ...
Neurobehavioral abnormalities resulting from developmental exposure to drugs or neurotoxicants represent a major societal liability. A great deal of attention has been paid to identifying the ...
The study will test the therapy in lung, colorectal, and head and neck cancer patients with B7H3 and PTK7 mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback